These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23917320)

  • 21. Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
    Yeka A; Tibenderana J; Achan J; D'Alessandro U; Talisuna AO
    PLoS One; 2013; 8(1):e53772. PubMed ID: 23349741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
    Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
    Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
    Arinaitwe E; Sandison TG; Wanzira H; Kakuru A; Homsy J; Kalamya J; Kamya MR; Vora N; Greenhouse B; Rosenthal PJ; Tappero J; Dorsey G
    Clin Infect Dis; 2009 Dec; 49(11):1629-37. PubMed ID: 19877969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
    Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial.
    Gürkov R; Eshetu T; Miranda IB; Berens-Riha N; Mamo Y; Girma T; Krause E; Schmidt M; Hempel JM; Löscher T
    Malar J; 2008 Sep; 7():179. PubMed ID: 18796142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
    Yeka A; Dorsey G; Kamya MR; Talisuna A; Lugemwa M; Rwakimari JB; Staedke SG; Rosenthal PJ; Wabwire-Mangen F; Bukirwa H
    PLoS One; 2008 Jun; 3(6):e2390. PubMed ID: 18545692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the Western Amazon region of Brazil.
    Alecrim MG; Lacerda MV; Mourão MP; Alecrim WD; Padilha A; Cardoso BS; Boulos M
    Am J Trop Med Hyg; 2006 Jan; 74(1):20-5. PubMed ID: 16407341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania.
    Joseph D; Kabanywanyi AM; Hulser R; Premji Z; Minzi OM; Mugittu K
    Malar J; 2013 Feb; 12():60. PubMed ID: 23399782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
    Wang SQ; Christophel E; Lin SG; Meng F; Hu XM; Wang GZ; Liu J; Zeng LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):50-2. PubMed ID: 18637586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.
    Mutagonda RF; Kamuhabwa AA; Minzi OM; Massawe SN; Maganda BA; Aklillu E
    Malar J; 2016 May; 15(1):278. PubMed ID: 27177586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
    Salman S; Page-Sharp M; Griffin S; Kose K; Siba PM; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5306-13. PubMed ID: 21876056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria.
    Sugiarto SR; Singh B; Page-Sharp M; Davis WA; Salman S; Hii KC; Davis TME
    Br J Clin Pharmacol; 2022 Feb; 88(2):691-701. PubMed ID: 34296469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria.
    Wanzira H; Kakuru A; Arinaitwe E; Bigira V; Muhindo MK; Conrad M; Rosenthal PJ; Kamya MR; Tappero JW; Dorsey G
    Clin Infect Dis; 2014 Aug; 59(4):509-16. PubMed ID: 24825870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.
    Kredo T; Mauff K; Van der Walt JS; Wiesner L; Maartens G; Cohen K; Smith P; Barnes KI
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5616-23. PubMed ID: 21947399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.
    Hatz C; Soto J; Nothdurft HD; Zoller T; Weitzel T; Loutan L; Bricaire F; Gay F; Burchard GD; Andriano K; Lefèvre G; De Palacios PI; Genton B
    Am J Trop Med Hyg; 2008 Feb; 78(2):241-7. PubMed ID: 18256423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.